Radius Health (RDUS) Misses Q4 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Radius Health (RDUS) Misses Q4 EPS by 13c

Radius Health Reports Fourth Quarter and Full Year 2015 Financial and Operating Results

February 25, 2016 6:30 AM EST

Management to host conference call today at 7:30 am ET.Radius submitted an MAA in Europe for the investigational drug abaloparatide-SC for the potential treatment of postmenopausal osteoporosis and reduction of fracture risk on November 17, 2015. The application has been validated by the EMA and is currently under regulatory review. Radius is on track to submit an NDA for abaloparatide-SC in the U.S. at the end of the first quarter of 2016.

WALTHAM, Mass., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Radius or the Company) (Nasdaq:... More